New agents for scintigraphy in rheumatoid arthritis

European Journal of Nuclear Medicine

Volumn 22, Issue 11, 1995, Pages 1339-1346

  de Bois, Marjolein H W ^a   Pauwels, Ernest K J ^a   Breedveld, Ferdinand C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human immunoglobulin; J001; Radiolabelled antibodies; Rheumatoid arthritis; Somatostatin receptors

Indexed keywords

ANTIBODY; ANTIRHEUMATIC AGENT; CD4 ANTIGEN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M;

CELL LABELING; DISEASE ACTIVITY; DRUG CHOICE; HUMAN; ISOTOPE LABELING; JOINT SCINTISCANNING; LEUKOCYTE; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; WHOLE BODY SCINTISCANNING;

ARTHRITIS, RHEUMATOID; HUMAN; IMMUNOCONJUGATES; JOINTS; RADIOIMMUNODETECTION;

EID: 0028823088     PISSN: 03406997     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/BF00801624     Document Type: Review

References (73)

1. Cellular basis for rheumatoid inflammation
2. The role of cytokines in the pathogenesis of rheumatoid arthritis
3. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair
4. Cytokine production in the rheumatoid joint; implications for treatment
5. Rheumatoid synovitis and pannus
6. Inflammation and repair
7. Lipid mediators of inflammation
8. Hypoxia, oxidative stress and rheumatoid arthritis
9. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected joints of patients with rheumatoid arthritis
10. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium
11. Pathogenesis of rheumatoid arthritis. A vascular hypothesis
12. Adhesion receptors of the immune system
13. The importance of the T cell initiating and maintaining the chronic synovitis of rheumatoid arthritis
14. The role of the neutrophil in rheumatoid arthritis
15. Pathogenesis of rheumatoid arthritis
16. Growth factors
17. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
18. Indium-111 leukocyte imaging in patients with rheumatoid arthritis
19. 111Indium-labelled leucocytes for measurement of inflammatory activity in arthritis
20. 99m-Tcm-labelled leucocyte imaging in active rheumatoid arthritis
21. The response of99mTcm-methylene disphosphonate and99mTcm-hexametazime-labelled neutrophils to intra-articular steroid injection in rheumatoid arthritis
22. In vivo leucocyte migration in arthritis
23. Detection of acute inflammation with indium-111 labeled nonspecific polyclonal IgG
24. In-111-labeled nonspecific immunoglobulin scanning in the detection of focal infection
25. Tc-99m-human immunoglobulin (HIG) — first results of a new agent for the localization of infection and inflammation
26. Imaging of inflammatory arthritis with technetium-99m-labeled IgG
27. Measurement of synovial inflammation in rheumatoid arthritis with technetium-99m labelled human polyclonal immunoglobulin G
28. Technetium-99m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis
29. 99mTc human immunoglobulin scintigraphy — a reliable method to detect joint activity in rheumatoid arthritis
30. Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids
31. Detection and quantitative analysis of joint activity inflammation with99m-Tem-polyclonal human immunoglobulin G
32. Joint scintigraphy for quantification of synovitis with99mTc-labelled human immunoglobulin G compared to late phase scintigraphy with99mTc-labelled disphosphonate
33. 99mTcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intraarticular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis
34. Technetium-99m labelled polyclonal human immunoglobulin G scintigraphy before and 26 weeks after initiation of parenteral gold treatment in patients with rheumatoid arthritis
35. Joint scintigraphy for quantification of synovitis with99mTc-labelled human immunoglobulin G compared to histological examination
36. Evaluation of disease activity in rheumatoid arthritis and other arthritides using technetium-99m labelled nonspecific human immunoglobulin
37. Autoradiographic method for quantitation of radiolabelled proteins in tissues using indium-111
38. Accumulation of immunoglobulin G at focal sites of inflammation
39. Biodistribution and kinetics of radiolabelled proteins in rats with focal infection
40. Dissociation of indium from indium-111-labelled diethylene triamine pentaacetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci
41. Binding of99mTc-labelled polyclonal human immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection
42. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation
43. Diagnosing infections in febrile granulocytopenic patients with indium-111 labeled human IgG
44. Potential of indium-111 to measure inflammatory arthritis
45. Immunodiagnosis and immunodetection of colorectal cancer
46. Radioimmunodetection in cancer identification
47. From monoclonal antibodies to peptides and molecular recognition units: an overview
48. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis
49. Imaging rheumatic joint diseases with anti-T lymphocyte antibody OKT-3
50. Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies
51. Comparison on99mTcm-labelled specific murine anti-CD4 monoclonal antibodies and nonspecific human immunoglobulin for imaging inflamed joints in rheumatoid arthritis
52. Joint uptake and body distribution of a technetium-99m-labeled anti-rat-CD4 monoclonal antibody in rat adjuvant arthritis
53. Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody
54. Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin
55. Targeting endothelial activation in inflammation using111In-labelled anti-E-selectin monoclonal antibody
56. Somatostatin and the immune and haematopoetic system: a review
57. Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis
58. Binding of a membrane proteoglycan from klebsiella pneumonia and its derivatives to human leukocytes
59. Binding of a bacterial acylpoly (1,3) galactoside to human blood leucocytes
60. Scintigraphy with JOOIX, a klebsiella membrane glycolipid, for the early diagnosis of chronic berylliosis: results from an experimental model
61. Scintigraphic potentials of J001X acylated polygalactoside for imaging inflammatory lesions in pigs
62. Scintigraphy with J001 macrophage targeting glycolipopeptide. A new approach for sarcoidosis imaging
63. Imaging of synovitis in rheumatoid arthritis with radionuclide tracers
64. New approaches to targeting arthritis with radiopharmaceuticals
65. Biodistribution of an anti-interleukin 2 receptor monoclonal antibody in rat recipients of a heart allograft, and its use as a rejection marker in gamma scintigraphy
66. Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of123iodine-interleukin 2
67. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of123I-interleukin-2; an early sign of type 1 diabetes
68. New approach for in vivo detection of insulitis in type 1 diabetes: activated lymphocyte targeting with123I-labelled interleukin 2
69. Binding, internalization and excretion of TNF α-dextran associated radioactivity in cultured human glioma cells
70. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells
71. Lymphoscintigraphy with123I-labelled epidermal growth factor